• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS TOTAL PSA; PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS TOTAL PSA; PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS Back to Search Results
Catalog Number 08791732190
Medical Device Problem Codes Incorrect Measurement (1383); High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/24/2026
Type of Reportable Event Malfunction
Event or Problem Description
The initial reporter stated they received questionable results for one patient sample tested with elecsys total psa and elecsys free psa on a cobas e 801 analytical unit.This medwatch will apply to the total psa assay.Please refer to the medwatch with a1.Patient identifier (b)(6) for information related to the free psa assay.No questionable results were reported outside of the laboratory as the results did not match the patient's clinical diagnosis.The sample resulted in total psa values of 0.10 ng/ml and 0.0972 ng/ml.The sample resulted in free psa values of 0.535 ng/ml and 0.530 ng/ml.The sample was treated with polyethylene glycol (peg) and the tests had a low recovery rate.Dilution studies showed abnormal recovery with the higher dilution ratios.No specific data was provided.
 
Additional Manufacturer Narrative
The serial number of the e 801 analyzer is (b)(6).Samples from the patient were provided for investigation.The investigation is ongoing.
 
Additional Manufacturer Narrative
Investigations of the patient's samples were able to reproduce the results obtained by the customer.When treated with a heterophilic antibody blocking tube, there was no evidence of heterophilic antibody interference.Spiking experiments determined the patient's sample contained an interfering factor against a component of the total psa assay.Per product labeling, "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design." for diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings.The investigation did not identify a product issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS TOTAL PSA
Common Device Name
PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
natalie catton
9115 hague road
indianapolis, IN 46250
MDR Report Key24898939
Report Number1823260-2026-01456
Device Sequence Number8859144
Product Code MTF
UDI-Device Identifier07613336165980
UDI-Public07613336165980
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
P990056/S039
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 05/12/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/31/2026
Device Catalogue Number08791732190
Device Lot Number86528303
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/24/2026
Supplement Date Received by Manufacturer04/23/2026
Initial Report FDA Received Date04/16/2026
Supplement Report FDA Received Date05/12/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient SexUnknown
Patient EthnicityNon Hispanic
Patient RaceAsian
-
-